ATE327745T1 - Wässrige injizierbare suspensionen für tiere enthaltend florfenicol - Google Patents

Wässrige injizierbare suspensionen für tiere enthaltend florfenicol

Info

Publication number
ATE327745T1
ATE327745T1 AT03017323T AT03017323T ATE327745T1 AT E327745 T1 ATE327745 T1 AT E327745T1 AT 03017323 T AT03017323 T AT 03017323T AT 03017323 T AT03017323 T AT 03017323T AT E327745 T1 ATE327745 T1 AT E327745T1
Authority
AT
Austria
Prior art keywords
florfenicol
aqueous injectable
injectable suspensions
animals containing
suspensions
Prior art date
Application number
AT03017323T
Other languages
English (en)
Inventor
Erwin Embrechts
Jan Embrechts
Original Assignee
Emdoka Bvba Drug Registration
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emdoka Bvba Drug Registration filed Critical Emdoka Bvba Drug Registration
Application granted granted Critical
Publication of ATE327745T1 publication Critical patent/ATE327745T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT03017323T 2003-07-31 2003-07-31 Wässrige injizierbare suspensionen für tiere enthaltend florfenicol ATE327745T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03017323A EP1502589B1 (de) 2003-07-31 2003-07-31 Wässrige injizierbare Suspensionen für Tiere enthaltend Florfenicol

Publications (1)

Publication Number Publication Date
ATE327745T1 true ATE327745T1 (de) 2006-06-15

Family

ID=33522319

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03017323T ATE327745T1 (de) 2003-07-31 2003-07-31 Wässrige injizierbare suspensionen für tiere enthaltend florfenicol

Country Status (13)

Country Link
US (1) US8362087B2 (de)
EP (1) EP1502589B1 (de)
CN (1) CN1829503B (de)
AT (1) ATE327745T1 (de)
AU (1) AU2004262501B2 (de)
CA (1) CA2532755C (de)
DE (1) DE60305687T2 (de)
DK (1) DK1502589T3 (de)
ES (1) ES2266695T3 (de)
PL (1) PL223349B1 (de)
PT (1) PT1502589E (de)
SI (1) SI1502589T1 (de)
WO (1) WO2005013959A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20091171A1 (es) * 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol
ES2690550T3 (es) * 2011-01-13 2018-11-21 Austin Research Labs Corp. Dispersiones de alta carga para el tratamiento de infecciones
EP2683364B1 (de) 2011-03-10 2017-01-18 Xeris Pharmaceuticals, Inc. Stabile formulierungen zur parenteralen injektion von peptidwirkstoffen
EP2773331B1 (de) 2011-10-31 2016-02-10 Xeris Pharmaceuticals, Inc. Formulierungen zur behandlung von diabetes
US9125805B2 (en) * 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
CN102920655A (zh) * 2012-11-26 2013-02-13 哈尔滨市华农威普动物保健品有限公司 氟苯尼考混悬注射液及其制备工艺
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
CN103145594B (zh) * 2013-03-26 2014-12-17 四川农业大学 一种制备氟苯尼考微晶体的方法
AU2015300944B2 (en) 2014-08-06 2019-07-11 Xeris Pharmaceuticals, Inc. Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
US9649364B2 (en) 2015-09-25 2017-05-16 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic formulations in aprotic polar solvents
US11590205B2 (en) 2015-09-25 2023-02-28 Xeris Pharmaceuticals, Inc. Methods for producing stable therapeutic glucagon formulations in aprotic polar solvents
US11020403B2 (en) 2017-06-02 2021-06-01 Xeris Pharmaceuticals, Inc. Precipitation resistant small molecule drug formulations
AT519742B1 (de) * 2017-09-22 2018-10-15 Rene Weilharter Schusswaffe
CN108904442B (zh) * 2018-08-09 2021-04-06 山西瑞象生物药业有限公司 一种氟苯尼考溶液剂及其制备方法
CN108863864B (zh) * 2018-08-16 2020-07-24 天津大学 一种氟苯尼考-柠檬酸共晶及其制备方法
KR102199186B1 (ko) * 2019-02-13 2021-01-06 주식회사 이글벳 병원성 세균에 의한 질병의 예방 및 치료용 수의학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235892A (en) * 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
FR2560613B2 (fr) * 1983-05-16 1987-03-27 Pechiney Aluminium Perfectionnement aux barres cathodiques comportant une semelle metallique, pour cuves d'electrolyse hall-heroult
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5646151A (en) * 1996-03-08 1997-07-08 Adolor Corporation Kappa agonist compounds and pharmaceutical formulations thereof
US6074657A (en) * 1997-03-20 2000-06-13 Pharmacia & Upjohn Company Administration of an injectable antibiotic in the ear of an animal
US6787568B1 (en) * 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation

Also Published As

Publication number Publication date
CN1829503B (zh) 2010-06-23
EP1502589B1 (de) 2006-05-31
WO2005013959A1 (en) 2005-02-17
US8362087B2 (en) 2013-01-29
AU2004262501B2 (en) 2008-11-20
CA2532755C (en) 2011-10-04
DE60305687D1 (de) 2006-07-06
EP1502589A1 (de) 2005-02-02
CN1829503A (zh) 2006-09-06
US20060223889A1 (en) 2006-10-05
DE60305687T2 (de) 2007-02-22
PT1502589E (pt) 2006-10-31
CA2532755A1 (en) 2005-02-17
PL379701A1 (pl) 2006-11-13
ES2266695T3 (es) 2007-03-01
PL223349B1 (pl) 2016-10-31
SI1502589T1 (sl) 2006-12-31
AU2004262501A1 (en) 2005-02-17
DK1502589T3 (da) 2006-09-25

Similar Documents

Publication Publication Date Title
ATE327745T1 (de) Wässrige injizierbare suspensionen für tiere enthaltend florfenicol
ES2244831T5 (es) Uso de pantenol y/o ácido pantoténico y ácido hialurónico y/o hialuronato para la producción de una composición farmacéutica para aplicación oftalmológica
CY1121461T1 (el) Συνθεσεις που περιλαμβανουν δυσδιαλυτους στο νερο φαρμακευτικους παραγοντες και αντιμικροβιακους παραγοντες
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
EP3000481A3 (de) Peptidvermittelte nicht-kovalente verabreichung von wirkstoffen über die blut-hirn-schranke
ATE428401T1 (de) Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten
RU2010129238A (ru) Применение производных изотиоцианата в качестве противомиеломных средств
ECSP066599A (es) Método para el tratamiento de la enfermedad asociada con adamts-5
TR201907575T4 (tr) Hayvan parazitlerini kontrol etmeye yönelik faydalı ajanlar olarak aminobenzamid türevleri.
ATE541554T1 (de) Synergistische konservierungsmischungen
CU20080114A7 (es) Emulsión intravenosa de butilftalida y aplicación de la misma
BRPI0507657A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, método para tratar um distúrbio, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo
BR122019021714B1 (pt) preparação compreendendo vitamina b12 e butanol e butafosfano, e seu uso
BRPI0508052A (pt) derivados de lactamo tetracìclico e seus usos
BR0213124A (pt) Alimentos para animais incluindo ativos e métodos de uso dos mesmos
BRPI0416882A (pt) composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
WO2015111666A1 (ja) メガリン拮抗剤
ECSP066476A (es) Preparación de una infusión que comprende ácido (2r)-2-propiloctanoico como ingrediente activo
EP4249069A3 (de) Wässrige lösung enthaltend 1-(4-{[4-(dimethylamino)-1-piperidinyl]carbonyl}phenyl)-3-{4-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl}harnstoff
JPS6242924A (ja) 駆虫剤および殺菌剤組成物
BR0011845A (pt) Complexo farmacêutico
KR20140024862A (ko) 히알루론산 또는 히알루론산염을 포함하는 수용액
ATE250609T1 (de) Adamantanderivat und dies enthaltendes wässriges desinfektionsmittel
EA201170164A1 (ru) 9-замещенные-в-карбоксиоксадиазинохинолиновые производные, их получение и их применение в качестве антибактериальных средств
DE602006016168D1 (de) 1,3,5-triazepin-dionen zur Behandlung von Malaria

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1502589

Country of ref document: EP